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DOI: 10.1039/c2jm31030aHerein, the phase-transfer reaction of quantum dots (QDs) with amine-terminated polyamidoamine
(PAMAM) dendrimers with controllable ligand molar ratios was achieved. The unique properties of
PAMAM allowed us to build up structurally and electrostatically stabilized water soluble QD
complexes. Synthesized conjugates were characterized in terms of fluorescence and UV-Vis profiles,
hydrodynamic size, number of surface dendrimer groups, and stability. Cytotoxic effects of conjugates
for MCF-7, A-549 and HEP-G2 cancer cells were assessed based on cell viability using MTT assay.
Cytotoxicity results were expressed as no observable adverse effect concentration (NOAEC), 50%
inhibitory concentration (IC50) and total lethal concentration (TLC) values (mM). Furthermore, HER2
receptor-mediated targeting efficiency of antibody labelled P/QDs conjugates was evaluated by
successful staining of MCF-7 cells with bioconjugates. Uniquely, effective cell internalization was
achieved with well-characterized antibody coupled P/QDs in contrast to antibody free P/QDs
conjugates. Fluorescence microscopy images demonstrated that the designed PAMAM-derivatized
QDs nanoparticles show great potential in the areas of cellular imaging and targeted therapy.Introduction
In the last decade semiconductor nanocrystals (so-called
quantum dots, QDs) have been introduced as a new type of
biolabelling agent. QDs have unique optical properties in
comparison to organic fluorophores, such as broad absorption
spectra, narrow emission in combination with broad-band exci-
tation allowing multi-color labelling of different compartments/
structures/processes simultaneously, reduced tendency to pho-
tobleaching, and long fluorescence lifetime.1Also QDs have large
surface areas to interact with therapeutic and diagnostic agents
which makes QDs ideal for multifunctional imaging agents.2
Many articles3–12 and reviews13–18 deal with biological applica-
tions of colloidal QDs. As fluorescent markers, QDs are
commonly used to visualize cellular structures, certain
compounds inside the cells to investigate cellular processes, and
label tumor cells. Since it was proved that quantum dots are
incorporated by living cells,19 the uptake of those nanocrystals
into cells became important in applications such as gene, drug,
and nucleic acid delivery.20
The synthesis of highly fluorescent quantum dots (QDs) is
generally performed in organic solvents such as trioctylphosphine
oxide (TOPO) and hexadecylamine (HDA) at high temperatureaEge University, Faculty of Science, Biochemistry Department, 35100
Bornova-Izmir, Turkey. E-mail: suna.timur@ege.edu.tr; Fax: +90 232
3438634; Tel: +90 232 3438634
bGottfried Wilhelm Leibniz University of Hannover, Institute for Technical
Chemistry, Callinstr. 5, 30167 Hannover, Germany. E-mail: stahl@iftc.
uni-hannover.de; Fax: +49 511 7623004; Tel: +49 511 7622968
This journal is ª The Royal Society of Chemistry 2012(>200 C).21 The resulting monodisperse QDs are coated with
hydrophobic organic compounds. Thus they form sterically
stabilized colloids in non-polar solvents and coagulate in polar
solvents. For biosensing applications, QDs have to be conjugated
to biological molecules. This necessitates transfer of QDs into
aqueous solutions which is quite challenging. In order to mediate
water solubility, the surfactant layer of the QDs should be
replaced or coated with another layer introducing electrostatic
charge or hydrophilic head groups, which trigger water solubility.
It is crucial to determine a reliable surface processing chemistry
for QDs. Highly branched dendritic macromolecules such as
polyamidoamine (PAMAM) provide a unique surface ofmultiple
chains terminated with functional groups for synthetic
approaches. Their multiple conjugation sites provide densely
functionalized and structurally stable architectures.22 PAMAM
with variable terminal groups can be effectively applied to modify
QDs surfaces. However, amine-terminated dendrimers exhibit
some advantages which are electrostatic stabilization of QDs by
their polyelectrolyte nature, high cell association capability,
improved membrane permeation ability (especially those of
higher generation),23,24 and high buffering capacity that promotes
endosomal escape. Ingested QDs are not accessible to cytosol so
they are stored in vesicles. By virtue of the strong buffering
capacity of primary and tertiary amines, PAMAM can mediate
escape from internal vesicles.25–28 On the other hand, this endo-
somal escape process will prevent quantum dots losing their
fluorescence under acidic conditions in vesicles.29
So far there are at least four intensively identified nanotech-
nology platforms that represent precise nanostructures: I)J. Mater. Chem., 2012, 22, 11529–11536 | 11529
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View Article Onlinenanotubes, II) fullerenes, III) quantum dots and IV) dendrons/
dendrimers.30 In our work, we combined the above mentioned
advantageous characteristics of PAMAM dendrimers with
effective fluorescence properties of CdSe/ZnS QDs in order to
design well characterized water soluble QD conjugates. To the
best of our knowledge, the use of PAMAMdendrimers to modify
QDs for biological applications is very recent.27,30 Mostly thiol-
terminated dendrons/dendrimers were utilized to encapsulate
nanocrystals.30–33 Since thiol groups are very active to photoox-
idation,32 other functional moieties such as amine, hydroxyl,
carboxylic acid, phosphine oxide, and phosphonic oxide are
under consideration. Recently, Zhao et al. (2010) synthesized
folate-poly(ethylene glycol)-PAMAM functionalized QDs to
evaluate cellular uptake by HeLa cells. That study is the only one
to date that modifies QDs surface with amine-terminated den-
drimer ligands.34
Herein, water solubilization of QDs via amine-terminated
PAMAM dendrimers with controllable ligand densities was
successfully achieved. Afterwards, the effects of surface charge
and density of the PAMAM ligands on cellular targeting were
examined. In order to investigate the application of the designed
PAMAM/QDs conjugates, the conjugates were coupled to
HER2 antibodies to label MCF-7 human breast cancer cells
through HER2 receptor-mediated endocytosis. The cellular up-
take of antibody coupled PAMAM/QDs was examined under
fluorescence microscopy.Results
Characterization studies
PAMAM generation 5 (P-G5) dendrimers with amine surface
groups were used as a coating agent for HDA capped QDs. After
the mixture of QD nanocrystals and PAMAM solution was
incubated for 15 h, PAMAM/QD complexes were precipitated
with ethyl acetate. The supernatant was discarded and the
precipitant was dissolved in PBS buffer. Clearly, QDs were
transferred to the polar phase at the end of the procedure. Amine
groups of the original surface ligands (HDA) were replaced with
the amine groups of PAMAMduring the reaction. Fig. 1 outlines
the direct ligand-exchange reactions between PAMAMFig. 1 Ligand exchange reaction between HDA-stabilized QDs and
PAMAM-G5 dendrimers. Terminal amine groups of HDAwere replaced
with terminal amine groups of PAMAM. Resulting PAMAM-modified
QDs complexes (P/QDs) were dissolved in PBS buffer pH 7.4.
11530 | J. Mater. Chem., 2012, 22, 11529–11536dendrimer ligands and HDA-stabilized CdSe/ZnS core-shell
QDs (HDA-QDs).
The effect of conjugation on fluorescence characteristics of the
QDs was examined via fluorescence spectroscopy. The fluores-
cence spectrum of PAMAM-derivatized QDs shows that there
isn’t any significant shift of the maximum emission peak in
comparison with free QDs at 563 nm (Fig. 2A). This result
indicates that despite water solubilization of QDs, fluorescent
properties of QDs don’t exhibit any major changes. UV-vis
spectra of free QDs and PAMAM molecules have absorbance
maxima at 545 nm and 280 nm respectively (Fig. 2B). Con-
trasting those with the UV-vis profiles of PAMAM-attached
QDs, the same peaks at 280 nm for PAMAM and 545 nm for
QDs demonstrate successful coupling of PAMAM to the QDs.
Additionally, coupling of antibodies doesn’t result in any
changes in the optical properties of QDs either.
Further, QDs were modified with different amounts of
PAMAM and Bradford assay was used to estimate the numbers
of PAMAM molecules coupled to the QDs. The Bradford assay
is based on an absorbance shift of the dye Coomassie Brilliant
Blue G-250.35 Under acidic conditions the reddish form of the
dye is converted into its bluer form to bind to the molecule being
assayed. The formation of the complex between dye and mole-
cule is caused by the ionic interactions between the negative
charge of the dye and positive charges of primary and tertiaryFig. 2 Fluorescence (A) and, UV-vis (B) spectra of unmodified QDs,
PAMAM-modified QDs, and HER2 specific antibody-coupled P/QDs
conjugates. (A) Surface modification process didn’t cause any major
changes in fluorescence properties of QDs. Insert shows specific peaks at
280 nm for PAMAM and 545 nm for QDs at P/QDs conjugates proving
a successful ligand-exchange reaction.
This journal is ª The Royal Society of Chemistry 2012
Fig. 4 Size distribution of PAMAM and PAMAM-modified QDs
conjugates in aqueous solution. Results showed that PAMAMmolecules
have a hydrodynamic diameter of 5.61  0.0003 (black line), while QDs
modified with 14 PAMAM molecules (P14/QDs) have a hydrodynamic
diameter of 32.67  0.216 nm (red line), and P28/QDs particles have
58.77  0.029 nm (blue line) hydrodynamic diameters. Values are the
mean  standard deviation of the data (N ¼ 3).
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View Article Onlineamine groups of PAMAM. The bound form of the dye has an
absorption maximum at 595 nm. Accordingly, by using cali-
bration curve for PAMAM with a linear range 0.1 mM–2.5 mM
(y ¼ 0.994x  0.005; R2 ¼ 0.999), it was calculated that
a maximum of 28 PAMAM molecules were coupled to QD.
Fig. 3 gives estimated numbers of PAMAM bound to the QD
surface and their corresponding fluorescence intensities. The
fluorescence of P/QDs conjugates increases as a function of
increasing number of PAMAM molecules until it reaches
maximum binding point. The yield of the surface modification
processes in terms of PAMAM coupling efficiency is 93.3% in the
case of 30-fold molar excess of PAMAM involved in the reaction.
The hydrodynamic diameters of P/QDs conjugates were
evaluated by using dynamic light scattering (DLS). Particle
diameters of free PAMAM (P-G5), QDs modified with ca. 14
(P14/QDs), and ca. 28 (P28/QDs) PAMAM molecules are given
in Fig. 4. According to the DLS results, the size of PAMAM G5
dendrimers was estimated to be 5.6 nm, which is consistent with
the early reported size of Tomalia-type PAMAMG5 dendrimers
with amine surface functionalities which is 5.7 nm.22 While P14/
QDs nanoparticles had narrow distributions around 32.7 nm,
P28/QDs particles feature a wide distribution around 58.8 nm
indicating relatively heterogeneous size distribution. Unmodified
QDs in toluene have a size of approximately 3.7 nm. The increase
in size of QDs is reasonable because surface coating with a layer
of PAMAM increases the radius of nanocrystals due to the
expanded hydrated layer. In addition to DLS, the size of P14/
QDs conjugate was also evaluated with SEM. The size of the
lyophilized form of P14/QDs was calculated to be 31.81 
3.40 nm. Even though hydrodynamic size doesn’t indicate real
size, DLS and SEM results for P14/QDs conjugates seem to be in
good agreement. Reduced size of QD-based probes is essential to
achieve better tumor targeting and cellular uptake.36 Thus, P14/
QDs conjugates were taken into consideration for further studies
because of their relatively small size and homogeneous size
distribution.Fig. 3 Normalized fluorescence of QD nanoparticles modified with 10-,
20-, 30-, and 50-fold molar excess of PAMAM. Inset numbers indicate
PAMAM molecules conjugated per QD calculated via Bradford assay.
9.8  0.02, 19.5  0.12, 28.0  0.10, and 25.7  0.96 PAMAMmolecules
were estimated to be conjugated per QD when QD nanocrystals were
treated with 10-, 20-, 30-, and 50-fold excess of PAMAM molecules
respectively. Briefly, a maximum of approximately 28 PAMAM mole-
cules can cover a QD surface. Values are the mean  standard deviation
of the data (N ¼ 3).
This journal is ª The Royal Society of Chemistry 2012Photostability
Enhanced photostability is of particular importance for long-
term experiments, e.g. for time-resolved studies, such as fluo-
rescence labelling of transport processes in cells, or tracking the
path of single membrane-bound molecules.37 A major advantage
of using QDs instead of organic fluorophores for bioanalytical
purposes is their increased photostability. QDs in chloroform or
toluene do not show any photobleaching. In contrast, modified
QDs undergo fast photooxidation when they are transferred to
polar solvent via phase-transfer reactions. Polymer coatings seem
to enable photooxidation at surface defects of the QDs.38 When
PAMAM-derivatized QDs were stored in the dark, they
remained fluorescent for at least 4 weeks without any significant
decrease in their fluorescence intensities (data not shown).Evaluation of cytotoxicity
Dose dependent cytotoxicity effects of P/QDs were evaluated by
using standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) assays. Toxic effects of QDs don’t only
arise from nanocrystals themselves but also from surface
covering molecules.39,40 Cationic nanoparticles are often
considered to be cytotoxic agents, due to their electrostatic
interactions with negatively charged glycocalyx on cell
membranes.41 Thus it is essential to evaluate the toxicity effects
of the PAMAM-coated QDs (P14/QDs) using the international
standard test for in vitro cytotoxicity (ISO 10993-5) applying
MTT for cell viability. Fig. 5 shows the cell viability data
obtained from P14/QDs conjugates at different QDs concentra-
tions. Despite the potentially toxic effects of PAMAM at
concentrations higher than 5.0 mM,42 QDs induce cell growth
inhibition at even lower concentrations. In this study, MCF-7
and typical model cell lines A-549 and HEP-G2 were exposed to
P14/QDs conjugates up to 0.5 mM QDs where concentration of
conjugated PAMAM was 7.0 mM, for 4 h at 37 C. Since nativeJ. Mater. Chem., 2012, 22, 11529–11536 | 11531
Fig. 5 The effect of P14/QDs concentration on the survival of MCF-7,
A-549 and HEP-G2 cells treated with P14/QDs conjugates at 0.002, 0.01,
0.02, 0.05, 0.1, 0.2 and 0.5 mM for 4 h. A) Cell viability results evaluated
via MTT assay, B) dose–response curves extrapolated from MTT data.
After 4 h of treatment with P14/QDs conjugates at concentrations higher
than 0.1 mM, decrease in cell viability was observed for A-549 cells.
However, in the case of MCF-7 and HEP-G2 cells, conjugates up to
0.5 mM didn’t cause any significant toxic effect. Values are the mean 
standard deviation of the data (N ¼ 4).
Table 1 Calculated cytotoxicity values for P14/QDs conjugates using
MTT assay. Cytotoxicity results based on cell viability data were
expressed as no observable adverse effect concentration (NOAEC), 50%
inhibitory concentration (IC50) and total lethal concentration (TLC)
values (mM). P14/QDs conjugates have toxic influence on cell prolifera-
tion at A-549 cells with IC50 0.373 mM
Cell lines IC50 (mM) NOAEC (mM) TLC (mM)
MCF-7 1.549 0.320 3.427
A-549 0.373 0.065 0.996
HEP-G2 0.885 0.218 1.762
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View Article OnlineQDs are dispersed in toluene, the MTT test couldn’t be per-
formed with native QDs because toluene elicited very high
toxicity to the cells (data not shown). It has been found that QDs
with a stable polymer coating such as PAMAM are essentially
nontoxic to the MCF-7 and HEP-G2 cells. Thus, it can be
claimed that toxicity does not arise from even PAMAM mole-
cules on QD surface. However, they have an effect on cellular
ATP production or cell replication of A-549 at the QDs
concentration higher than 0.1 mM.
Cytotoxicity data obtained from the MTT assay was extrap-
olated using exponential regression analysis which was based on
an equation derived from the exponential equation
(y ¼ 1 1
1þ eaðbxÞ), where a is the curve slope, b is IC50 (50%
inhibitory concentration) and x is the concentration of sample
(Fig. 5B). IC50 was determined automatically while calculating
the equation. Also, NOAEC (no observable adverse effect
concentration) and TLC (total lethal concentration) were
determined using similar equations. Estimated toxicity values in
terms of IC50, NOAEC and TLC are displayed in Table 1.
According to the results, P/QDs conjugates are more toxic for11532 | J. Mater. Chem., 2012, 22, 11529–11536A-549 (IC50 0.373 mM) cells than MCF-7 (IC50 1.549 mM) and
HEP-G2 cells (IC50 0.885 mM).In vitro studies
When QDs are coupled with biological molecules such as
receptor ligands, specific uptake occurs via receptor-mediated
endocytosis. Besides specific binding, transport across cellular
membranes can be achieved with non-specific binding of poly-
cationic ligands as well. Amine-terminated dendrimers are
reported to bind to cells in a non-specific manner owing to
positive charge.43 By partial acetylation of surface amine groups
of PAMAM43–46 or adding biocompatible polymers such as
PEG,47 some studies tried to cope with this problem. Herein
possible non-specific interactions as a function of ligand density
and surface charge were examined by treating MCF-7 cells with
QDs conjugates derivatized with two different amounts of
PAMAM molecules (14 and 28 molecules). Fluorescence images
of the cells are represented in Fig. 6. Obviously, P28/QDs
conjugates were attached to the cell surface much more effec-
tively than P14/QDs conjugates could attach. Thus, it can be
claimed that P14/QDs conjugates potentially have negligible
interactions with cell surfaces.
For in vitro cellular uptake experiments, P14/QDs conjugates
have been utilized in targeting a breast cancer cell line (MCF-7)
by coupling the HER2 receptor specific antibody to the P/QDs
conjugates. Covalent attachment of the antibody to P14/QDs
conjugates was achieved by applying a EDC/NHS cross-linking
reaction. It has been reported that HER2-overexpressing cells
internalize targeted molecules via HER2 receptor-mediated
endocytosis.46,48 Fluorescence microscopy images of MCF-7 cells
labelled with P/QDs-AntiHER2 conjugates at 0.9 and 0.5 mM
QDs concentrations are shown in Fig. 7. It can be seen that
conjugates with 0.9 mM QDs were totally spread out in the
cytosol (Fig. 7A) whereas P/QDs-AntiHER2 with a lower
concentration (0.5 mM) of QDs (Fig. 7B) stayed on the outer
membrane after 4 h of incubation. In order to check if the
internalization process is driven by endocytotic pathways, MCF-
7 cells were incubated with P/QDs-AntiHER2 conjugates and P/
QDs conjugates at 4 C. According to the fluorescence images
illustrated in Fig. 8, it is apparent that HER2 specific antibody
labelled P/QDs conjugates are taken up into the cell via endo-
cytotic pathways.Discussion
The ligand-exchange reaction between PAMAM and QDs is
based on the strong binding affinity of multiple amine groups toThis journal is ª The Royal Society of Chemistry 2012
Fig. 6 Fluorescence microscopy images of MCF-7 cells treated with (A)
QDs nanocrystals modified with ca. 28.0 PAMAM dendrimers, and (B)
QDs nanocrystals modified with ca. 14.1 PAMAM dendrimers for 4 h.
Possible non-specific interactions of P/QDs conjugates with cells were
examined as a function of density of surface groups. QDs with 28
PAMAM molecules interact with cell surface much more intensively via
electrostatic interactions compared to QDs with 14 PAMAM molecules.
Fig. 7 Cellular uptake of P/QDs-AntiHER2 conjugates. (A) MCF-7 cell
treated with Anti-HER2 coupled P/QDs conjugates at 0.9 mM QDs
concentration, and (B) with 0.5 mM QDs concentration. Right panel
shows the bright field images of cells, and the left panel shows the QDs
fluorescence at 563 nm. Cells are observed under fluorescence microscopy
after 4 h of incubation at 37 C.
Fig. 8 Evaluation of MCF-7 cells incubated with (A) Anti-HER2
coupled P/QDs conjugates at 0.9 mMQDs concentration, (B) with 0.5 mM
QDs concentration, and (C) 0.5 mM P/QDs conjugates. Right panel
shows the bright field images of cells, and the left panel shows the QDs
fluorescence at 563 nm. Cells are observed under fluorescence microscopy
after 4 h of incubation at 4 C.
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View Article Onlinezinc atoms on the QD surface. It has been found that it is
essential to use the same coordinating groups for the exchange
reaction; that is, one primary amine group in the original capping
ligand is exchanged with another primary amine group in the
multivalent ligand. This strategy allows the creation of more
stable polymer-derivatized QDs.47 QDs originally stabilized with
a mixture of TOPO/HDA were also exposed to the same ligand-
exchange reaction with PAMAM. However, aggregates formed,
showing the inefficient ligand-exchange reaction between TOPO
and PAMAM and uncontrolled adsorption of dendrimers to the
QDs surfaces. This also proves that when the ligand-exchange
reaction is carried out between the same functional groups, the
efficiency of the surface modification process becomes much
better. On the other hand, it is worth mentioning that giving QDs
a hydrophilic surface consisting of PAMAMmolecules decreases
the fluorescence of quantum dots. That is to say, the fluorescence
efficiency of hydrophobic QDs is much higher in organic solvents
than that of hydrophilic QDs in aqueous solutions.38 Although,
they do retain their basic optical properties such as the absorp-
tion and emission spectrum profiles (Fig. 2). Furthermore, theThis journal is ª The Royal Society of Chemistry 2012remaining fluorescence signal is strong enough to label the cells
and evaluate them under fluorescence microscopy due to the
reduced photobleaching effect of QDs.
When QDs were modified with different amounts of PAMAM
as illustrated in Fig. 3, it was found out that the QD surface is
covered with a maximum of 28 PAMAM molecules with
a coupling yield of 93.3%. Concomitant increasing fluorescence
intensities imply that the increase in ratio of PAMAM results in
an increase of QD nanoparticles solubilized in water through
phase-transfer reactions. When the QD surface was totally
covered with PAMAM, fluorescence of conjugates reached
a steady state which means no more QDs pass through the water
phase. The coverage of QDs should be dictated by steric effects.
However these steric effects are likely balanced by interchain
interactions arising from the intervoid structure of PAMAM,
which may form densely packed structures on the QD surface.
Thus, the QD surface reaches a maximum binding point by
virtue of these restoring interactions.
In the case of surface processing of QDs via ligand-exchange
reactions, it is very challenging to obtain controllable ligand
ratios on the QD surface with high coupling efficiencies.
Apparently, efficient phase-transfer reaction of QDs was
accomplished, which is attributed to the electrostatic stabilizing
feature of multiple positive groups of PAMAM dendrimers. It is
important to mention that the ligand-exchange reaction is based
on the binding affinity of amines to Zn atoms, which causes
solubilization of QDs. Zinc atoms and amines are hard acid and
hard bases, respectively. It is well known that hard acid–hardJ. Mater. Chem., 2012, 22, 11529–11536 | 11533
Pu
bl
ish
ed
 o
n 
13
 A
pr
il 
20
12
. D
ow
nl
oa
de
d 
by
 T
ec
hn
isc
he
 In
fo
rm
at
io
ns
bi
bl
io
th
ek
 (T
IB
) o
n 2
6/1
0/2
01
7 1
3:1
1:0
0. 
View Article Onlinebase interactions are stronger than hard acid–soft base interac-
tions. Thus, strong binding affinity may exhibit a leading role in
stabilization of QDs, along with electrostatic interactions. Since
PAMAM has interior void structures,22 there might be inter-
molecular interactions between PAMAM molecules on the QDs
surface. In other words, PAMAM molecules could interact with
neighboring PAMAMmolecules. Further, these interactions can
be supported by hydrogen bond networking which is formed by
terminal amine groups of PAMAM.30 Dendrimer chains with
steric crowding characteristics may also allow closely packed
structure on the QDs surface which results in improved fluores-
cence efficiency.32 As a consequence, these anticipated mecha-
nisms may form packed densely PAMAM molecules on QD
surface which in turn promote structural stabilization. Evidently,
it can be asserted that the surface manipulating strategy that was
applied to QD allowed us to create QD probes with better
understandable structural properties which control or determine
future aspects of QDs.
The issue of cell responses to a variety of nanoparticles may be
specified by cell surface morphology, cell specific surface recep-
tors and their characteristic distribution in those cells. It can be
claimed that the different surface morphology of A-549 cells
makes the cells more susceptible to the cytotoxic effects of P/QDs
than that of MCF-7 and HEP-G2 cell lines (Fig. 5). This
assumption is supported by a study of Patra et al. that reported
gold nanoparticles (GNP) induce cell death response in A-549
cells. On the other hand, the two other cell lines tested, BHK21
(baby hamster kidney) and HEP-G2, remained unaffected by
GNP treatment.49Moreover, Choi et al. demonstrated that PEG-
derivatized phospholipid coated Fe3O4 and MnO metal oxide
nanoparticles elicited a more toxic effect for A-549 cells than that
of MCF-7 cells according to live/death cell and LDH assay kit
after 2 h of incubation.50 Although obtained results for in vitro
cytotoxic effect of P/QDs conjugates were promising, the trans-
ferability of the data to in vivo experiments is not clear yet.
In the cell culture experiments, a striking difference was
observed between the cells treated with P14/QDs and P28/QDs
conjugates (Fig. 6). Cells became distinguishable when they were
stained with P28/QDs conjugates due to the higher density of
dendrimer molecules, and therefore a higher density of surface
positive charges, on the QD surface. On the other hand, lower
ligand density on the QD surface weakened the electrostatic
interactions of P14/QDs conjugates with the cell surface, which
were not strong enough to visualize the cells. Hence, P/QDs
conjugates containing 14.1 0.46 PAMAMmolecules were used
for antibody coupling and further cell targeting experiments due
to their reduced size and reduced non-specific interactions in
order to improve specific targeting efficiency.
As mentioned before, cationic polymers have a strong pH-
buffering capacity. In acidic organelles this enhances proton
adsorption and builds up osmotic pressure across the cell
membrane. This process in turn promotes the endosomal escape
and release of the polymer to the cytosol.28,47 QDs are trapped in
endosomes/lysosomes after internalization, resulting in the irre-
versible destruction of photochemical fluorescence of QDs,
caused by a pH value of around 4.0–5.0.29,51,52 In order to utilize
QDs for cellular targeting and drug delivery studies, these
disadvantages should be overcome. Surface derivatization of
QDs with PAMAM, which possesses strong buffering capacity,11534 | J. Mater. Chem., 2012, 22, 11529–11536is expected to accelerate endosomal escape, which prevents
photobleaching of QDs. This enhances cytoplasmic migration of
QDs in cells and at the same time increases the photostability of
QDs during long-term treatments. Fluorescence microscopy
images demonstrate effective attachment and cellular internali-
zation of the HER2 receptor specific antibody targeted P/QDs
conjugates (Fig. 7). Combination of the conjugates with an
antibody represents a potentially viable method with better
specificity and enhanced cellular targeting efficiency in compar-
ison to that of label free P/QDs conjugates. After 4 h of incu-
bation, P/QDs-AntiHER2 bioconjugates not only bound to
outer surface but also internalized into the cells whereas
P14/QDs conjugates could only interact inefficiently with the cell
surface in a non-specific manner (Fig. 6B). As a result, it was
proved that structurally stabilized bioconjugates with the
enhanced photo-brightness of QDs, the strong buffering capacity
of PAMAM, and the presence of a targeting moiety lead to
efficient in vitro labelling and imaging of tumor cells.Conclusions
Researches in quantum dot (QD) probe design and development
have focused on synthesis, solubilization and coupling of QDs
with target-specific ligands. Several strategies are being used to
manipulate surface ligands as well as their molar ratios with
respect to QDs. However, the ‘best’ QD probes with controlled
ligand molar ratios aren’t available yet. Herein, we described
surface processing of quantum dots (QDs) with amine-termi-
nated polyamidoamine (PAMAM) dendrimers with controllable
molar ratios of PAMAM. We conclude that PAMAM den-
drimers with amino moieties are found to solubilize QDs in
aqueous solvents through ligand-exchange reactions. It was
found that ligand density on the QD surface has a major effect on
possible non-specific interactions with cell surfaces. The most
challenging aspects of the use of amine groups are their
concentration-dependent toxic effects and their non-specific
interactions with cell surfaces. When we switched to cell culture
experiments, we tried to eliminate those foreseen undesired
interactions by manipulating the ligand density on the QD
surface. As a result, a large part of the non-specific interactions
were eliminated. Fluorescence microscopy images of cells stained
with antibody coupled P/QDs conjugates proved that non-
specific interactions are reduced regardless. These extracted
results will suggest better surface processing strategies to take
one step towards finding the ‘best’ QD nanocomplexes. The in
vitro application studies presented above show that PAMAM-
derivatized QDs conjugates targeted with HER2 receptor specific
antibodies are capable of labelling cancer cells in a specific
manner. It should be emphasized that well characterized
P/QDs conjugates allowed us to build up engineered devices with
up-and-coming features for cell targeting and imaging
experiments.
Although the cited studies have promising points, further
studies should focus on detailed physical parameters such as
surface charge and colloidal stability which determine QDs
ability to interact with cell surface, be endocytosed, escape from
endosomes, and/or enter the nucleus, and biological interactions
for different cells/processes.53 The results presented in this study
will suggest important guidelines to highlight some of theseThis journal is ª The Royal Society of Chemistry 2012
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View Article Onlineconcerns in order to design multifunctional dendrimer based
quantum dots as fluorescent probes for cellular imaging.Materials and methods
Chemicals
PAMAM dendrimer (P-G5; ethylenediamine core, generation
5.0 solution), ethyl acetate ($99.8%), tetramethylammonium
hydroxide solution (25 wt% in methanol), N-(3-dimethylamino-
propyl)-N0-ethylcarbodiimide hydrochloride (EDC), N-hydrox-
ysuccinimide (NHS) and CdSe/ZnS (560 nm, 5 mg mL1 in
toluene, HDA ligand coated, 694630) were purchased from
Sigma-Aldrich. Phosphate buffer saline (PBS) was prepared with
8.01 g L1 sodium chloride, 0.2 g L1 potassium chloride,
1.44 g L1 disodium hydrogen phosphate and 0.24 g L1 potas-
sium dihydrogen phosphate, pH 7.4. Anti-HER2 (c-erbB-2)
Clone TAB250 as well as Minimum Essential Medium powder
(MEM) were obtained from Invitrogen. Dulbecco’s Modified
Eagle’s Medium powder-high glucose (DMEM), human insulin
solution and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) were purchased from Sigma-Aldrich.
Sodium dodecyl sulfate (SDS) was provided by Applichem. All
other medium ingredients were purchased from PAA Labora-
tories GmbH. The applied human cancer cell lines MCF-7
(breast cancer), A-549 (lung cancer), HEP-G2 (liver cancer) were
ordered from DSMZ (German Collection of Microorganisms
and Cell Cultures).Synthesis of water soluble P/QDs conjugates
0.5 mL of CdSe/ZnS core-shell QDs in toluene solution (5.0 mM),
0.5 mL of the PAMAM G5 dendrimer in methanol solution
(150 mM) and 50 mL tetramethylammonium hydroxide solution
wereadded toa vial.Themixturewas shaken for 15hat 30 C.Then
2.0 mL ethyl acetate was added to the vial to precipitate the nano-
crystal complexes. The solution was centrifuged and the purified
PAMAM coated CdSe/ZnS QDs were dissolved in PBS buffer
solution. Unconjugated PAMAM dendrimers were separated via
filtration with 50 kDa MWCO centrifugal membrane tubes (Mil-
lipore Amicon Ultra 0.5 mL, USA). The number of coupled
PAMAMmolecules was estimated by using Bradford reactive.Conjugation of Anti-HER2 antibody to P/QDs conjugates
(P/QDs-AntiHER2)
Toactivate the carboxyl-terminusof the antibody, 0.1MEDCand
0.25MNHS solutions in 25.0mMpH6.0MES buffer were added
to Anti-HER2 antibodies (0.01 mg mL1). After 15 minutes
constant shakingat roomtemperature, aqueous solutionofP/QDs
at 5.0mMQDs concentration in pH7.4PBSbufferwas added.The
solution was stirred for 2 hours at room temperature for antibody
conjugation. Unconjugated antibodies, P/QDs and excess EDC
and NHS were removed by centrifugation with 300 kDa MWCO
membrane filtration tubes (VWRNanosep Omega, Germany).Fluorescence measurements
Fluorescence spectra of QDs conjugates were measured by using
2.0 mL of sample with a Nanodrop 3300 spectrofluorometerThis journal is ª The Royal Society of Chemistry 2012(Thermo Fisher Scientific Inc. USA) in terms of relative fluo-
rescence units (RFU). The effect of conjugation on the fluores-
cence characteristics of QDs nanoparticles was examined
according to the fluorescence spectrum. Also absorbance of
conjugates was measured with a NanoDrop 1000 spectropho-
tometer (Thermo Fisher Scientific Inc. USA).
Size characterization
The hydrodynamic diameters of P/QDs conjugates dissolved in
PBS pH 7.4 were evaluated by using dynamic light scattering
(DLS). DLS data were collected by using a Malvern DLS
apparatus (Nano-ZS) with a 633 nm He/Ne laser. JSM 6700F
NT model SEM (Scanning Electron Microscopy) was also used
to evaluate the size of the P/QDs conjugates.
Cell culture experiments
MCF-7 cell line was grown inMinimum Essential Medium Eagle
(MEM) modified with 10% fetal calf serum, 1.0 mM sodium
pyruvate, 2.0 mM L-glutamine, 10 mg mL1 insulin, 1.0% non-
essential amino acids and 10 mL L1 penicillin/streptomycin.
A-549 and HEP-G2 cell lines were grown in Dulbecco’s Modified
Eagle Medium (DMEM) containing 10% fetal calf serum and 1%
penicillin/streptomycin. Cells were cultured at 37 C in a moist
atmosphere containing 5.0% CO2. For incubation of the cells
with samples or during cytotoxicity tests the same conditions
were used.
In vitro cytotoxicity
Dose dependent cytotoxicity effects of P/QDs were evaluated by
using standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) assays. Briefly, in 96-well flat bottom
tissue plates abundantly populated MCF-7 and typical model
cell lines, A-549 and HEP-G2, were treated with P/QDs conju-
gates at 0.5, 0.2, 0.1, 0.05, 0.02, 0.01 and 0.002 mM QDs
concentrations for 4 h. Then the samples were removed
completely to avoid any reactions of MTT with reducing
components of the medium or sample. To work out the cytotoxic
effects of the different P/QDs concentrations, cells were incu-
bated with 110 mL/well MTT solution (10%, 5.0 mg mL1 PBS) in
medium for 4 h. Living cells with metabolic activity are able to
reduce the yellow MTT to a purple-colored formazan complex
inside the cells. Then 100 mL SDS (1.0 g SDS in 10 mL 0.01 M
HCl) was applied to the wells to dissolve the purple crystals.
After 24 h of incubation, UV-Vis absorption was measured at
570 nm with 630 nm as reference wavelength. Therefore,
a microplate reader Model 680 (BioRad) was used.
Fluorescence microscopy
Fluorescence microscopy images were captured with an Olympus
IX50 (Olympus America Inc.) fluorescence microscope equipped
with a digital camera (Olympus, C3040-ADU, Japan). The
images were processed with Cell^B image analysis software
(Olympus, Japan). For monitoring fluorescence labelled cells,
excitation filter U-MNB (filter), DM500 (dichroic mirror),
BP470-490 (exciter filter), BA515 (barrier filter) were used.
Before labelling MCF-7 cells with P/QDs-AntiHER2 conjugates,J. Mater. Chem., 2012, 22, 11529–11536 | 11535
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View Article Onlinethe cells were seeded out in 96-well flat bottom tissue plates. After
3 days of cultivation, wells were populated abundantly, old
culture medium was discarded and cells were washed twice with
PBS. Afterwards, cells were treated with 100 mL of conjugate
diluted with medium, and incubated for 4 h at 37 C. Finally,
cells were rinsed twice with PBS to remove excess conjugate.
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